-
Shanghai Refreshgene Therapeutics Co., Ltd. Successfully Doses First Patient in Phase I/IIa Clinical Trial of RRG001 Intraocular Injection
Dec 28 2023 -
NeuExcell’s NXL-004 Secures FDA Orphan Drug Designation for Glioma Treatment
Dec 25 2023 -
Warm congratulations to GeneVector on the IND acceptance of its first AAV gene therapy pipeline using a two-plasmid packaging system
Nov 30 2023 -
Tauopathy’s Role in Aβ Oligomer Formation: New Insights from Transgenic Primate Models on Alzheimer’s Pathogenesis
Sep 28 2023 -
Targeted Lysosomal Degradation of Mutant Huntingtin by Engineered Intrabody Peptide SM3
Sep 25 2023 -
Researchers Unveil a Novel Strategy for Protein Miniaturization in the CRISPR-Cas System
Sep 20 2023 -
PackGene Biotech and Kudo Biotechnology Partner to Offer Customized mRNA Manufacturing Services
Sep 19 2023 -
Zolgensma’s Success in SMA Treatment Advocates for AAV-based Gene Therapy and Promises a Bright Future for Genetic Disorders
Apr 03 2023 -
International Rare Disease Day | PackGene GMP plasmid is DMF registered, helping drug applications and shining lights on rare disease therapy!
Mar 01 2023